Group 1 - The T. Rowe Price Dividend Growth ETF (TDVG) is an actively managed ETF that primarily invests in large-cap, high dividend-paying American-listed stocks [1] - T. Rowe Price is promoting its expertise in identifying value within North American public equities and ETFs, highlighting the competitive landscape among asset managers [1] Group 2 - Nikola has over three years of experience in finance and consulting, focusing on corporate credit risk analysis and venture capital in the med-tech sector [1] - Nikola has recently assisted investors in identifying better ETF options amidst a crowded market of similar offerings [1]

Core Insights - The article discusses the expertise of Nikola in finance and consulting, particularly focusing on North American public equities and ETFs [1] - Nikola has experience in corporate credit risk analysis, government consulting, and venture capital analysis in the med-tech sector [1] - The article highlights Nikola's recent efforts to assist investors in identifying better ETF options amidst a crowded market [1] Summary by Categories Professional Experience - Nikola has over three years of experience in finance and consulting [1] - His background includes corporate credit risk analysis and consulting for government entities [1] - He has also engaged in venture capital analysis specifically in the med-tech space [1] Investment Focus - Nikola is focused on finding value in North American public equities and ETFs [1] - He aims to help investors narrow down better options for ETFs, as many asset managers offer similar products [1]

Group 1 - Nikola has over three years of experience in finance and consulting, focusing on North American public equities and ETFs [1] - His professional background includes corporate credit risk analysis, consulting for government entities, and venture capital analysis in the med-tech sector [1] - Recently, Nikola has assisted investors in identifying better ETF options amidst a crowded market of similar offerings [1] Group 2 - The article does not provide any stock, option, or derivative positions in the companies mentioned, nor does it plan to initiate any within the next 72 hours [2] - The opinions expressed in the article are solely those of the author and not influenced by any business relationships with the companies discussed [2]